Moreover, using in silico transcriptomic data of GBM samples, we analyzed if ERs activities, as transcriptional regulators, could be related to those EZH2, as an approach to explore whether E2 mediates EZH2 activation through a genomic mechanism via its ERs. The gene discussed is EZH2; the disease is glioblastoma.